Documentation needed for medical device reimbursement in Japan includes regulatory approval, clinical trial data, safety & efficacy evidence, cost-effectiveness analysis, comparison with existing devices, and detailed product specifications. Additional materials like economic evaluations, post-market surveillance plans, and marketing authorization are required for submission to MHLW and Chuikyo under the NHI framework.
